Will McAdoo

Will McAdoo is the Global Development Science Director at AstraZeneca, where they focus on innovative approaches in immuno-oncology. Prior to this role, Will served as a Global Patient Safety Fellow and conducted significant research at the University of Virginia, exploring the Notch3 cell signaling pathway related to lung cancer. Will earned a Doctor of Pharmacy from the University of North Carolina at Chapel Hill, bridging a background in chemistry and biochemistry with advanced pharmaceutical studies.